News
-
-
-
-
-
COMMUNIQUÉ DE PRESSE
Relief Therapeutics and NeuroX, Successor to MindMaze, Sign Definitive Agreement for Business Combination
Relief Therapeutics and NeuroX sign definitive agreement for business combination to create MindMaze Therapeutics Holding SA. Transaction poised to advance evidence-based neurotherapeutic solutions and precision medicine -
-
-
COMMUNIQUÉ DE PRESSE
Relief Therapeutics Publishes 2025 Half-Year Report
Relief Therapeutics published its 2025 half-year report, highlighting progress in pipeline candidates for rare diseases and financial status. Corporate update includes advances in wound care and liquid formulation for phenylketonuria -
-